JPRN-C000000331已完成未知
The protective effects of Telmisartan on the cardiovascular system - The protective effects of Telmisartan on the cardiovascular system
Department of Cardiovascular Science and Medicine, Chiba University Graduate School of Medicine0 个研究点目标入组 100 人开始时间: 2006年2月21日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 30years-old 至 70years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •*Secondary hypertension *heart failure *diabetes mellitus *acute myocardial infarction within 6 months *treated with PCI within 6 months *cerebrovascular disease within 3 months *severe renal failure (serum creatinine>3mg/dl *severe hepatic failure *malignant disease
研究者
相似试验
尚未招募
4 期
Protective effects of telmisartan on heart problems due to medicine (doxorubicin) in patients with breast cancerCTRI/2019/05/019245ICMR
终止
2 期
Telmisartan in the management of abdominal aortic aneurysmAbdominal Aortic AneurysmACTRN12611000931976James Cook University208
招募中
不适用
Therapeutic efficacy and safety of telmisartan in patients with non-alcoholic fatty liver disease (NAFLD) and hypertension: exploratory researchon-alcoholic fatty liver disease and hypertensionJPRN-UMIN000020537Department of General Internal Medicine, Kyushu University Hospital50
进行中（未招募）
不适用
Effects of Telmisartan on Arterial Stiffness Assessed by the Cardio-ankle Vascular Index in Hypertensive Patientsarterial stiffnessCardiovascular - HypertensionhypertensionACTRN12610000125022Keio University School of Medicine100
已完成
不适用
The effect of telmisartan on endothelial function in hypertensive patients.HypertensionJPRN-UMIN000005034Seigo Sugiyama20